JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 3 February 2006. doi:10.1136/jcp.2005.027722
Journal of Clinical Pathology 2006;59:367-372
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2005.027722v1
59/4/367    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinto, A E
Right arrow Articles by Soares, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinto, A E
Right arrow Articles by Soares, J
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Breast Cancer

ORIGINAL ARTICLE

Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation

A E Pinto1, L Roque2, R Rodrigues2, S André1, J Soares1

1 Department of Pathology, CROL, SA, Lisbon, Portugal
2 Cytogenetic Laboratory of Molecular Pathobiology Research Centre (CIPM) of Portuguese Cancer Institute, CROL, SA, Lisbon

Correspondence to:
Dr António E Pinto
Departamento de Patologia Morfológica, Instituto Português de Oncologia, CROL, SA, R Prof Lima Basto, 1099-023 Lisbon, Portugal; aepinto{at}ipolisboa.min-saude.pt Objective: To investigate underlying genetic events associated with complex DNA ploidy breast carcinomas.

Methods: Screening for chromosome imbalances was carried out using comparative genomic hybridisation (CGH) in 14 frozen samples of tumour from a series of 13 breast cancer patients with multiploid (n = 11) and hypertetraploid (n = 2) tumours. They had previously been analysed by DNA flow cytometry and also assessed immunohistochemically for p53 tissue expression. Ploidy status was determined on frozen samples using the Multicycle software program.

Results: The total number of copy gains (n = 242) was significantly greater than the number of copy losses (n = 51). The mean (SD) number of gains per sample was 17.3 (5.7), and of losses, 3.6 (4.2) (p = 0.0001). Gains of chromosomal regions at 1q (14/14; 100%), 7q (12/14; 85.7%), and 3q (11/14; 78.6%), as well as 1p, 2q, 5p, 8q, and 13q (10/14; 71.4%) were the most frequent aberrations in this series. Losses were most commonly found on 17p (5/14; 35.7%). Three patients dying of the disease had tumours with high level amplifications at 1q12-qter, 3q22–q25, and 8q22–q23 regions. Six cases had p53 overexpression, of whom four showed 12q gains and two showed 17p losses.

Conclusions: There is a very high incidence of genetic aberrations, mainly related to chromosomal gains, in this subgroup of aneuploid breast cancer patients, associated with a poor clinical outcome. The 7q locus, not previously reported as showing frequent changes in breast cancer, was found to be a potential site for some candidate oncogenes.


Abbreviations: CGH, comparative genomic hybridisation; DI, DNA index; FCM, flow cytometry; TNM, "tumour, node, metastasis" classification; UICC, International Union Against Cancer

Keywords: breast cancer; DNA flow cytometry; comparative genomic hybridisation; multiploid/hypertetraploid tumours




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Savage, M. B.K. Lambros, D. Robertson, R. L. Jones, C. Jones, A. Mackay, M. James, J. L. Hornick, E. M. Pereira, F. Milanezi, et al.
Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis
Clin. Cancer Res., January 1, 2007; 13(1): 90 - 101.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.